Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.

[1]  Hamidreza Ghandehari,et al.  Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[2]  M. Shive,et al.  Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[3]  D. Tomalia,et al.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.

[4]  James R. Baker,et al.  The Synthesis and Testing of Anti-Cancer Therapeutic Nanodevices , 2001 .

[5]  Mitch Jacoby.  CUSTOM-MADE BIOMATERIALS: Applying engineering, materials, and chemistry principles, researchers produce safe, smart, and effective implantable devices , 2001 .

[6]  K. Kono,et al.  Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.

[7]  R. Juliano,et al.  Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. , 2000, Nucleic acids research.

[8]  N. McKeown,et al.  Polyamidoamine Starburst dendrimers as solubility enhancers. , 2000, International journal of pharmaceutics.

[9]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[10]  K. Kono,et al.  Design of dendritic macromolecules containing folate or methotrexate residues. , 1999, Bioconjugate chemistry.

[11]  J. Fréchet,et al.  Designing dendrimers for drug delivery. , 1999, Pharmaceutical science & technology today.

[12]  R. Zhuo,et al.  In vitro release of 5-fluorouracil with cyclic core dendritic polymer. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[13]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[14]  R. Langer,et al.  Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. , 1998, Biomaterials.

[15]  F. Doyle,et al.  Preparation and characterization of glucose-sensitive P(MAA-g-EG) hydrogels , 1997 .

[16]  P. Russo,et al.  Light scattering and fluorescence photobleaching recovery study of poly(amidoamine) cascade polymers in aqueous solution , 1996 .

[17]  G. Socrates,et al.  Infrared characteristic group frequencies : tables and charts , 1994 .

[18]  Peter J. Tarcha,et al.  Polymers for Controlled Drug Delivery , 1990 .

[19]  C. Hawker,et al.  Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .

[20]  William A. Goddard,et al.  Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .

[21]  Lisbeth Illum,et al.  Polymers in Controlled Drug Delivery , 1988 .

[22]  George R. Newkome,et al.  Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol , 1985 .

[23]  George R. Newkome,et al.  MICELLES. PART 1. CASCADE MOLECULES: A NEW APPROACH TO MICELLES. A (27)-ARBOROL , 1985 .

[24]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .

[25]  M. K. Aravind,et al.  Determination of ibuprofen by high-performance liquid chromatography. , 1998, Journal of chromatography.

[26]  E. Pretsch.  Tables of spectral data for structure determination of organic compounds , 1983 .

[27]  G. Socrates,et al.  Infrared Characteristic Group Frequencies , 1980 .